Pharmaceuticals

Non-Opioid Pain Treatment Market Growth Patterns And Forecast Outlook Through 2030

May 1, 2026May 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Non-Opioid Pain Treatment Market Expected To Reach Based On Its 2026 Value?

The non-opioid pain treatment market size has shown robust expansion in recent years. This market is anticipated to expand from $55.31 billion in 2025 to $60.32 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.1%. Factors contributing to its historical growth include the increasing prevalence of chronic pain conditions, growing awareness regarding opioid-related risks, limited availability of non-opioid alternatives, a rise in orthopedic and musculoskeletal procedures, and an expansion of hospital and clinic infrastructure dedicated to pain management.

The non-opioid pain treatment market is projected to experience substantial expansion over the upcoming years. Its value is anticipated to reach $84.36 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.7%. This projected growth during the forecast period can be ascribed to several factors, including the advancement of innovative non-opioid therapeutic options, the broader implementation of digital health monitoring and telemedicine for pain management, an increasing uptake of combination therapies, escalating government initiatives aimed at pain management, and a growing influx of investment into personalized pain care and alternative treatments. Key developments anticipated in this period encompass the rising embrace of non-opioid approaches to pain management, an uptick in the utilization of medical cannabis and omega-3 fatty acid supplements, an increase in topical and injectable products for pain relief, the extension of pain management services within hospitals and clinics, and the incorporation of non-pharmacological interventions such as acupuncture and TENS.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27366&type=smp

What Major Factors Are Driving The Non-Opioid Pain Treatment Market Forward?

The escalating prevalence of sports-related injuries is anticipated to drive the future growth of the non-opioid pain treatment market. These injuries are defined as physical harm incurred during or as a consequence of sports or exercise activities. The increased occurrence of sports injuries is attributed to higher participation in high-intensity sports and recreational activities, exposing athletes to an elevated risk of physical trauma. Non-opioid pain treatment is effective for managing sports-related injuries by providing significant pain relief and reducing inflammation without the dangers linked to opioid use, thus fostering faster recuperation, improved functional ability, and safer sustained management. As an illustration, in October 2024, figures from Howden Group Holdings Ltd, a UK-based insurance intermediary company, revealed that Europe’s top five football leagues registered 4,123 injuries during the 2023-24 season, signifying a 4% increase compared to the previous season. Therefore, the expanding incidence of sports-related injuries is a key driver for the growth of the non-opioid pain treatment market.

How Is Segmentation Applied In The Non-Opioid Pain Treatment Market Segment Analysis?

The non-opioid pain treatment market covered in this report is segmented –

1) By Product: Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived, Other Products

2) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (Nsaids), Acetaminophen, Local Anesthetics, Antidepressants, Anticonvulsants, Corticosteroids, Other Drug Classes

3) By Route Of Administration: Oral, Topical, Injectable, Other Route Of Administrations

4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies

5) By Application: Orthopedic And Musculoskeletal Pain, Postoperative Pain, Cancer Pain, Neuropathic Pain, Other Applications

Subsegments:

1) By Medical Cannabis: Cannabidiol Based Products, Tetrahydrocannabinol Based Products, Combined Cannabinoid Products

2) By Menthol Containing: Topical Creams, Gels, Sprays

3) By Omega 3 Fatty Acid Containing: Fish Oil Derived Supplements, Algae Derived Supplements, Krill Oil Derived Supplements

4) By Botulinum Toxins: Onabotulinumtoxin A, Abobotulinumtoxin A, Incobotulinumtoxin A

5) By Capsaicin Derived: Low Concentration Creams, High Concentration Patches, Nasal Sprays

6) By Other Products: Magnesium Based Products, Acupuncture Devices, Transcutaneous Electrical Nerve Stimulation Devices

Which Trends Are Impacting The Progress Of The Non-Opioid Pain Treatment Market?

Leading companies operating within the non-opioid pain treatment market are prioritizing innovations in drug formulations, particularly non-opioid oral treatments, to provide effective pain relief and mitigate the risks associated with opioid use and addiction. Non-opioid oral treatment refers to pain-relieving medications administered orally that exclude opioids and function through alternative mechanisms, such as reducing inflammation, modulating nerve signals, or acting on specific receptors, to manage pain without the addiction potential or respiratory depression frequently linked to opioids. For instance, in July 2025, Vertex Pharmaceuticals Incorporated, a US-based biotechnology company, launched JOURNAVX, a pioneering non-opioid therapy designed to offer effective relief for moderate-to-severe acute pain. This cutting-edge non-opioid treatment employs targeted modulation of pain pathways, features a favorable safety profile, and delivers a rapid onset of action, thereby enabling strong pain control, a reduced dependency potential, and enhanced patient well-being. It ensures focused pain management, lowers addiction risks, and supports faster recovery and an improved quality of life for patients experiencing acute pain.

Who Are The Companies Participating In The Non-Opioid Pain Treatment Market Environment?

Major companies operating in the non-opioid pain treatment market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Limited, Vertex Pharmaceuticals Incorporated, SUN PHARMACEUTICAL INDUSTRIES LIMITED, Perrigo Company Public Limited Company, Dr. Reddy’s Laboratories, HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY, Pacira BioSciences Inc, Heron Therapeutics Inc, AFT Pharmaceuticals Limited, Vivozon Pharmaceutical Co. Ltd, Levicept Ltd, Algiax Pharmaceuticals GmbH, Latigo Biotherapeutics Inc, Hyloris Pharmaceuticals SA

Get The Full Non-Opioid Pain Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/non-opioid-pain-treatment-global-market-report

Which Region Is The Largest In The Non-Opioid Pain Treatment Market?

North America was the largest region in the non-opioid pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-opioid pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Non-Opioid Pain Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/non-opioid-pain-treatment-global-market-report

Browse Through More Reports Similar to the Global Non-Opioid Pain Treatment Market 2026, By The Business Research Company

Polyethylene Pipes Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyethylene-pipes-global-market-report

Polyethylene Pipes Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyethylene-pipes-global-market-report

Polyolefin Pipes Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyolefin-pipes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795